Anthera Pharmaceuticals (Anthera Pharmaceuticals) Dividend Payout Ratio : 0.00 (As of Mar. 2018)

View and export this data going back to 2010. Start your Free Trial

What is Anthera Pharmaceuticals Dividend Payout Ratio?

Anthera Pharmaceuticals's dividend payout ratio for the months ended in Mar. 2018 was 0.00.

The historical rank and industry rank for Anthera Pharmaceuticals's Dividend Payout Ratio or its related term are showing as below:

ANTH's Dividend Payout Ratio is not ranked ^*
in the Biotechnology industry.
Industry Median: 0.43
* Ranked among companies with meaningful Dividend Payout Ratio only.

As of today (2024-04-29), the Dividend Yield % of Anthera Pharmaceuticals is 0.00%.

Anthera Pharmaceuticals's Dividends per Share for the months ended in Mar. 2018 was $0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Anthera Pharmaceuticals Dividend Payout Ratio Historical Data

The historical data trend for Anthera Pharmaceuticals's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anthera Pharmaceuticals Dividend Payout Ratio Chart

Anthera Pharmaceuticals Annual Data

Trend

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dividend Payout Ratio

Get a 7-Day Free Trial

Anthera Pharmaceuticals Quarterly Data
	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18
Dividend Payout Ratio	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Anthera Pharmaceuticals's Dividend Payout Ratio

For the Biotechnology subindustry, Anthera Pharmaceuticals's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Anthera Pharmaceuticals's Dividend Payout Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Anthera Pharmaceuticals's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Anthera Pharmaceuticals's Dividend Payout Ratio falls into.

Anthera Pharmaceuticals Dividend Payout Ratio Calculation

Dividend payout ratio measures the percentage of the company's earnings paid out as dividends.

Anthera Pharmaceuticals's Dividend Payout Ratio for the fiscal year that ended in Dec. 2017 is calculated as

Dividend Payout Ratio	=	Dividends per Share (A: Dec. 2017 )	/	EPS without NRI (A: Dec. 2017 )
	=	0	/	-3.798
	=	N/A

Anthera Pharmaceuticals's Dividend Payout Ratio for the quarter that ended in Mar. 2018 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Mar. 2018 )	/	EPS without NRI (Q: Mar. 2018 )
	=	0	/	-0.568
	=	N/A

Anthera Pharmaceuticals (OTCPK:ANTH) Dividend Payout Ratio Explanation

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

Anthera Pharmaceuticals Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of Anthera Pharmaceuticals's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Anthera Pharmaceuticals (Anthera Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Anthera Pharmaceuticals Inc (OTCPK:ANTH) » Definitions » Dividend Payout Ratio

Comparable Companies

Traded in Other Exchanges

N/A

Address

25801 Industrial Boulevard, Suite B, Hayward, CA, USA, 94545

Website

http://www.anthera.com

Anthera Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing and commercializing products to treat serious diseases associated with inflammation, including cardiovascular and autoimmune diseases. The company currently has one Phase 3-ready clinical program and two Phase 2 clinical programs. It was established in 2004.

Executives

Christopher S Henney	director	10505 ROSELLE STREET, SAN DIEGO CA 92121
Shanahan William R Jr	officer: Chief Medical Officer	10301 STELLA LINK HOUSTON TX 77025
Brian Mueller	director	C/O BIOMARIN PHARMACEUTICAL INC., 105 DIGITAL DRIVE, NOVATO CA 94949
Paul F Truex	director	PENINSULA PHARMACEUTICALS, INC., 1751 HARBOR BAY PARKWAY, ALAMEDA CA 94502
Charles V Olson	officer: Chief Technology Officer	25801 INDUSTRIAL BLVD., SUITE B, HAYWARD CA 94545
Klara Dickinson	officer: Chief Regulatory Officer	C/O CYMABAY THERAPEUTICS, INC., 7575 GATEWAY BLVD., SUITE 110, NEWARK CA 94560
Steven B Engle	director	C/O XOMA LTD., 2910 SEVENTH STREET, BERKELEY CA 94710
James Pennington	officer: Interim Chief Medical Officer	25801 INDUSTRIAL BLVD, SUITE B, HAYWARD CA 94545
Hislop Colin	officer: Chief Medical Officer	C/O PENINSULA PHARMACEUTICALS, INC., 1751 HARBOR BAY PARKWAY, ALAMEDA CA 94502
Sanford S Zweifach	director	21720 23RD DRIVE SE, SUITE 150, BOTHELL WA 98021
Daniel K Spiegelman	director	MYRIAD GENETICS, 320 WAKARA WAY, SALT LAKE CITY UT 84003
Christopher P. Lowe	officer: CFO and Chief Business Officer	2511 N LOOP 1604,, SUITE 204, SAN ANTONIO TX 78258
James Healy	director	3000 SAND HILL ROAD, 4-250, MENLO PARK CA 94025
Orbimed Capital Gp Iv Llc	director	601 LEXINGTON AVENUE, 54TH FLOOR, NEW YORK NY 10022
Samuel D Isaly	director	601 LEXINGTON AVENUE, 54TH FLOOR, NEW YORK NY 10022

Anthera Pharmaceuticals (Anthera Pharmaceuticals) Headlines

From GuruFocus

Anthera Pharmaceuticals Announces Withdrawal of its Nasdaq Hearing Request and Suspension of Trading of its Securities on the NASDAQ Capital Markets

By Marketwired Marketwired • 06-27-2018

Major US Indexes End Higher Monday

By Julie Young • 11-08-2021

Anthera Pharmaceuticals Inc. Reports Operating Results (10-Q)

By gurufocus 10qk • 11-12-2010

Anthera Pharmaceuticals Inc. Reports Operating Results (10-Q)

By gurufocus 10qk • 08-12-2010

Anthera Pharmaceuticals Inc. Reports Operating Results (10-Q)

By gurufocus 10qk • 05-14-2010